SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

   Division of Geriatric Medicine

[Return To Index page]
photo Susan L. Greenspan, MD

Professor of Medicine

Director, Osteoporosis Prevention and Treatment Center

Email: greenspn@pitt.edu

Phone: 412-692-2477

Contact
Office: 1110 Kaufmann Building
3471 Fifth Ave.
Pittsburgh, PA 15213
 
Phone: 412-692-2477
Fax: 412-692-2486
E-mail: greenspn@pitt.edu
Administrative Assistant:
Joseph Madia
Email: joseph.v.madia@pitt.edu
Phone: 412-692-2477
Fax: 412-692-2486
Education and Training
Education
BA, Stanford University, 1975
MD, Harvard Medical School, 1979
Training
Intern, Beth Israel Deaconess Medical Center, 1980
Residency, Internal Medicine, Beth Israel Deaconess Medical Center, 1982
Postdoctoral Fellow, Endocrinology, Massachusetts General Hospital, 1985
Postdoctoral Fellow, Geriatrics, Beth Israel Deaconess Medical Center, 1986
Research Interest
Dr. Greenspan studies geriatric osteoporosis, including its pathophysiology, evaluation, and treatment, and at UPMC she serves as both Director of the Osteoporosis Prevention and Treatment Center and as Director of Bone Health at Magee Women’s Hospital. She also serves on NIH/NIA’s Board of Scientific Counselors and its Clinical Trial Advisory Panel. In addition, she is a member of the National Osteoporosis Foundation’s Board of Trustees and Chairs its Education Program. Her current R01-funded research focuses on osteoporosis in institutionalized elderly, including new treatment modalities and new assessments of bone strength. She is PI of both our NIH-funded “Pepper Center” (and Director of its Research Career Development Core) and our NIH T32 Program in Clinical Research Training-Geriatrics/Gerontology.
Clinical Interest
Dr. Greenspan is a Professor of Medicine, dually-trained in Geriatrics and in Endocrinology. She currently sees patients at the Benedum Geriatric Clinic located in Montefiore Hospital where she treats osteoporosis.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Greenspan, S. L., Resnick, N. M., Parker, R. A. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized, controlled trial. Journal of the American Medical Association. 2003; 289: 2525-2533.
Resnick, N.M., Greenspan, S.L. “Senile” osteoporosis reconsidered. Journal of the American Medical Association. 1989; 261: 1025-9.
Greenspan, S.L., Myers, E. R., Maitland, L.A., Resnick, N.M., Hayes, W. C. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. Journal of the American Medical Association. 1994; 271: 128-33.
Greenspan, S.L., Maitland, L. A., Myers, E. R., Krasnow, M. B., Kido, T. H. Femoral bone loss progresses with age: A longitudinal study in women over age 65. Journal of Bone Mineral Research. 1994; 9: 1959-65.
Greenspan, S. L., Myers, E. R., Kiel, D. P., Parker, R. A., Hayes, W. C., Resnick, N. M. Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. American Journal of Medicine. 1998; 104: 539-45.
Greenspan, S.L., von Stetten, E., Emond, S. K., Jones, L., Parker, R. A. Instant vertebral assessment: A noninvasive DXA technique to avoid misclassification and clinical mismanagement of osteoporosis. Journal of Clinical Densitometry. 2001; 4: 373-380.
Greenspan, S. L., Schneider, D. L., McClung, M. R., Miller, P. D., Schnitzer, T. J., Bonin, R., Smith, M. E., DeLucca, P., Gormley, G.J., Melton, M. E. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 2002; 136: 742-746.
Greenspan, S. L., Resnick, N. M., Parker, R. A. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: A 3-year, double -blind, placebo-controlled, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism. 2005; 90: 2762-2767.
Greenspan, S. L., Resnick, N. M., Parker, R. A. Vitamin D supplementation in older women. Journal of Gerontology: Medical Sciences. 2005; 60 (A): 754-759.
Greenspan, S. L., Bone III, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R., Zanchetta, J. R., Blosch, C.M., Mathisen, A. L., Marriott, T. B. Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Osteoporotic Women. Annals of Internal Medicine. 2007; 146(5): 326-39.
Sponsored Research/Activities
Title: Autoimmunity and Emphysema and Risk of Osteoporosis in Smokers
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL128289
Start Year: 2016
End Year: 2021
Title: Sustaining Skeletal Health in Frail Elderly
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG052123
Start Year: 2016
End Year: 2021
Title: Pittsburgh Older Americans Independence Center
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2015
End Year: 2020
Title: Maintenance of Skeletal Integrity in Frail Elders - Phase 2
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG050302
Start Year: 2015
End Year: 2020
Title: Integrating Patient-Centered Exercise Coaching into Primary Care to Reduce Fragility Fracture
Role: Co-Principal Investigator
Funding Agency: Penn State/Patient-Centered Outcomes Research Institute
Start Year: 2015
End Year: 2020
Title: Pittsburgh Older Americans Independence Center RCDC
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2015
End Year: 2020
Title: Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
Role: Co-Principal Investigator
Funding Agency: Brigham and Women's Hospital, Inc./National Institute of Aging
Grant Number: U01 AG048270
Start Year: 2014
End Year: 2019
Title: Advancing Geriatrics Infrastructure and Network Growth (AGING)
Role: Co-Investigator
Funding Agency: University of Massachusetts/National Institute of Aging
Grant Number: R24 AG045050
Start Year: 2014
End Year: 2018
Title: Vitamin D and Vascular Function in Obese Children
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL12985
Start Year: 2013
End Year: 2018
Title: Activating Patients to Reduce Osteoporosis (APROPOS)
Role: Co-Investigator
Funding Agency: University of Alabama at Birmingham/National Institute of Arthristis, Muscoskel, & Skin Disease
Grant Number: R01 AR060240
Start Year: 2013
End Year: 2016
Title: Obesity and Body Segment Parameters in Working Adults
Role: Co-Investigator
Funding Agency: National Institute for Occupational Safety and Health
Grant Number: R01 OH010106
Start Year: 2013
End Year: 2016
Title: Testosterone Trial
Role: Co-Investigator
Funding Agency: University of Pennsylvania/National Institute of Health
Grant Number: U01 AG030644
Start Year: 2013
End Year: 2015
Title: Osteoporosis Treatment Strategies: Comparative Effectiveness and Cost-Effectiveness
Role: Co-Investigator
Funding Agency: Swedish Health Services/National Institute of Arthristis, Muscoskel, & Skin Disease
Grant Number: R01 AR060809
Start Year: 2013
End Year: 2014
Title: Pittsburgh Older Americans Independence Center
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2013
End Year: 2013
Title: Dissemination of a Diabetes Prevention Program Among Medicare Eligible Retirees
Role: Co-Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: R18 DK096405
Start Year: 2012
End Year: 2017
Title: The Role of Teriparatide for Healing of Atypical Femoral Shaft Fractures
Role: Principal Investigator
Funding Agency: Eli Lilly Company
Grant Number: DRUG B3D-US-X035
Start Year: 2012
End Year: 2017
Title: Comparative Effectiveness and Cost-effectiveness of Osteoporosis Screening Strategies for Older Adults
Role: Co-Investigator
Funding Agency: Swedish Health Services/National Institute of Arthristis, Muscoskel, & Skin Disease
Grant Number: R01 AR060809
Start Year: 2012
End Year: 2014
Title: Comparative Effectiveness and Cost-Effectiveness of Osteoporosis Screening Strategies for Older Adults
Role: Co-Investigator
Funding Agency: National Institute of Arthristis, Muscoskel, & Skin Disease
Grant Number: R01 AR060809
Start Year: 2011
End Year: 2014
Title: University of Pittsburgh Clinical and Translational Science Institute (CRRF)
Role: Co-Investigator
Funding Agency: National Center for Research Resources
Grant Number: UL1 RR024153
Start Year: 2011
End Year: 2012
Title: Microbicides Trials Network
Role: Co-Investigator
Funding Agency: Magee Womens Hospital/National Institute of Allergy & Infectious Diseases
Grant Number: U01 AI068633
Start Year: 2008
End Year: 2013
Title: Global Longitudinal Registry of Osteoporosis in Women (GLOW)
Role: Co-Investigator
Funding Agency: University of Massachusetts
Start Year: 2008
End Year: 2012
Title: Osteoporosis in Older Men and Women
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: K24 DK062895
Start Year: 2008
End Year: 2012
Title: Maintenance of Skeletal Integrity in Frail Elders
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG028086
Start Year: 2007
End Year: 2014
Title: The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women with Breast Cancer Following Initiation of Aromatasa Inhibitor Therapy
Role: Principal Investigator
Funding Agency: Proctor & Gamble
Grant Number: DRUG
Start Year: 2007
End Year: 2013
Title: The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women with Breast Cancer Following Initiation of Aromatasa Inhibitor Therapy
Role: Co-Investigator
Funding Agency: Proctor & Gamble
Start Year: 2007
End Year: 2013
Title: Hip Strength Across the Menopausal Transition
Role: Co-Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG026463
Start Year: 2007
End Year: 2012
Title: Pittsburgh Older Americans Independence Center(RCDC)
Role: Core Leader
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2004
End Year: 2015
Title: Pittsburgh Older Americans Independence Center (Clinical Core RC1)
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2004
End Year: 2014
Notable Achievements
NIH/NIA Board of Scientific Counselors (BSC), 2011-present
NIH/NIA Clinical Trials Advisory Program (CTAP), 2014-present
Editorial Board, Journal of Gerontology: Medical Sciences, 1999-present
Editorial Board, Journal of Clinical Densitometry, 1998-present
Editorial Board, National Osteoporosis Foundation, 2004-present
Board of Trustees, National Osteoporosis Foundation, 2010-present
Chair, Education Committee, National Osteoporosis Foundation, 2013-present
Chair, International Society of Osteoporosis Annual Meeting, 2013-present
"Best Research Award" American Geriatrics Society Annual Meeting, 2014
Associate Diretor for Research, University of Pittsburgh Aging Institute, 2013-present